Fetalix offers a regenerative fetal-inspired biomaterial aimed at treating Low Back Pain (LBP) through a minimally invasive procedure.
Fetalix has raised $532K in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Fetalix's investors include European Innovation Council, EIC Accelerator, Portugal Ventures, Women TechEU, EIT Jumpstarter.
Fetalix is headquartered in Oporto, Portugal.
Fetalix offers a regenerative fetal-inspired biomaterial aimed at treating Low Back Pain (LBP) through a minimally invasive procedure.
Fetalix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fetalix — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/fetalix. Accessed August 14, 2026.
VCBacked. (2026). Fetalix — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/fetalix
{{cite web |title=Fetalix — Funding & Investors |url=https://www.vcbacked.co/company/fetalix |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated